All In Biotech

Free tool

FAERS Monitor: Solu-Medrol

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 011856 or its brand name (Solu-Medrol, Methylprednisolone Sodium Succinate). Reports on generic versions are filed under their own applications.

Reports

46,927

Serious

41,904

89% of reports

Hospitalization

20,309

Death reported

8,961

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use8,135
  • drug ineffective4,495
  • fatigue4,349
  • headache4,161
  • pain4,119
  • infusion related reaction4,031
  • nausea3,908
  • pyrexia3,843
  • dyspnoea3,716
  • rash3,258
  • arthralgia3,078
  • diarrhoea3,046
  • hypertension2,995
  • pneumonia2,944
  • vomiting2,894

Reports by year received

View as table
YearReports
2004620
2005732
2006630
2007782
2008777
2009789
2010995
20111,462
20121,369
2013998
20141,379
20151,856
20161,889
20171,907
20182,094
20193,063
20203,755
20213,426
20224,111
20233,747
20244,357
20253,953
20262,231

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,007,232 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
infusion related reactionSignal4,03129.028.1102,481
hypertensionSignal2,9956.46.213,627
pyrexiaSignal3,8435.04.912,444
off label useSignal8,1354.24.120,450
pneumoniaSignal2,9444.14.06,952
rashSignal3,2583.43.35,494
arthralgiaSignal3,0783.33.25,094
painSignal4,1193.02.95,688
headacheSignal4,1613.02.95,632
dyspnoeaSignal3,7163.02.94,905
vomitingSignal2,8942.82.73,325
fatigueSignal4,3492.52.44,086
nauseaSignal3,9082.22.22,705
diarrhoeaSignal3,0462.12.01,850
drug ineffective4,4951.51.5878

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.